DESTINATION: TEZEPELUMAB LONG-TERM SAFETY AND EFFICACY VERSUS PLACEBO IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA

被引：1
|
作者：
Menzies-Gow, A. [1 ]
Wechsler, M. E. [2 ]
Brightling, C. E. [3 ]
Korn, S. [4 ,5 ]
Bednarczyk, A. [6 ]
Ponnarambil, S. [7 ]
Almqvist, G. [8 ]
Lawson, K. [9 ,10 ]
Caveney, S. [11 ]
Bowen, K. [12 ]
Colice, G. [9 ]
机构：
[1] Royal Brompton & Harefield Hosp, London, England
[2] Natl Jewish Hlth, Denver, CO USA
[3] Univ Leicester, Inst Lung Hlth, NIHR Leicester Biomed Res Ctr, Leicester, Leics, England
[4] IKF Pneumol Mainz, Mainz, Germany
[5] Thoraxklin Heidelberg, Heidelberg, Germany
[6] AstraZeneca, BioPharmaceut R&D, Late Stage Dev Resp & Immunol, Warsaw, Poland
[7] AstraZeneca, BioPharmaceut R&D, Late Stage Dev Resp & Immunol, Cambridge, England
[8] AstraZeneca, BioPharmaceut R&D, Late Stage Dev Resp & Immunol, Gothenburg, Sweden
[9] AstraZeneca, BioPharmaceut R&D, Late Stage Dev Resp & Immunol, Gaithersburg, MD USA
[10] Cytel Inc, Cambridge, MA USA
[11] Amgen Inc, Global Dev, R&D, Thousand Oaks, CA USA
[12] AstraZeneca, BioPharmaceut R&D, Late Stage Dev Resp & Immunol, Biometr, Gaithersburg, MD USA
来源：
THORAX | 2022年 / 77卷
关键词：
D O I：
10.1136/thorax-2022-BTSabstracts.53
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
S47
引用
收藏
页码：A32 / A32
页数：1
相关论文
共 50 条
  • [11] Safety and efficacy of tezepelumab vs. placebo in adult patients with severe uncontrolled asthma: a systematic review and meta-analysis
    Abdelgalil, Mahmoud Shaban
    Elrashedy, Asmaa Ahmed
    Awad, Ahmed K.
    Gad, Eman Reda
    Ali, Mahmoud M.
    Farahat, Ramadan Abdelmoez
    Shawki, Bassant Hassan
    Abd-ElGawad, Mohamed
    SCIENTIFIC REPORTS, 2022, 12 (01):
  • [12] Long-term safety, efficacy, pharmacokinetics and pharmacodynamics of omalizumab in children with severe uncontrolled asthma
    Odajima, Hiroshi
    Ebisawa, Motohiro
    Nagakura, Toshikazu
    Fujisawa, Takao
    Akasawa, Akira
    Ito, Komei
    Doi, Satoru
    Yamaguchi, Koichi
    Katsunuma, Toshio
    Kurihara, Kazuyuki
    Teramoto, Takahide
    Sugai, Kazuko
    Nambu, Mitsuhiko
    Hoshioka, Akira
    Yoshihara, Shigemi
    Sato, Norio
    Seko, Noriko
    Nishima, Sankei
    ALLERGOLOGY INTERNATIONAL, 2017, 66 (01) : 106 - 115
  • [13] Oral and inhaled corticosteroid dose reductions with tezepelumab versus placebo in patients with severe, uncontrolled asthma from
    Wechsler, Michael E.
    Stolz, Daiana
    Lugogo, Njira L.
    Caveney, Scott
    Almqvist, Gun
    Bednarczyk, Artur
    Kotalik, Ales
    Chandarana, Shradha
    Ambrose, Christopher S.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2024, 12 (11):
  • [14] Efficacy and safety of tezepelumab in patients with uncontrolled disease while receiving maintenance therapy for moderate or severe asthma
    Corren, Jonathan
    Wechsler, Michael E.
    Chupp, Geoffrey
    Roseti, Stephanie L.
    Hellqvist, Asa
    Martin, Neil
    Llanos, Jean -Pierre
    Ambrose, Christopher S.
    Colice, Gene
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2023, 11 (03): : 943 - +
  • [15] TEZEPELUMAB EFFICACY ACCORDING TO BRONCHODILATOR REVERSIBILITY IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA IN NAVIGATOR
    Menzies-Gow, A.
    Bourdin, A.
    Korn, S.
    Cook, B.
    Ambrose, C.
    Ponnarambil, S.
    Hunter, G.
    Molfino, N.
    Colice, G.
    Llanos-Ackert, J.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (05) : S37 - S37
  • [16] Long-Term Safety and Efficacy of Mepolizumab in Patients with Severe Eosinophilic Asthma
    Albers, Frank C.
    Lugogo, Njira
    Gilson, Martyn J.
    Price, Robert
    Yancey, StevenW.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB14 - AB14
  • [17] DESTINATION: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the long-term safety and tolerability of tezepelumab in adults and adolescents with severe, uncontrolled asthma
    Andrew Menzies-Gow
    Sandhia Ponnarambil
    John Downie
    Karin Bowen
    Åsa Hellqvist
    Gene Colice
    Respiratory Research, 21
  • [18] Evaluation of long-term safety and efficacy of omalizumab in elderly patients with uncontrolled allergic asthma
    Tat, Tugba Songul
    Cilli, Aykut
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : 546 - 549
  • [19] Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR 
    Laidlaw, Tanya M.
    Menzies-Gow, Andrew
    Caveney, Scott
    Han, Joseph K.
    Martin, Nicole
    Israel, Elliot
    Lee, Jason K.
    Llanos, Jean-Pierre
    Martin, Neil
    Megally, Ayman
    Parikh, Bhavini
    Vong, Sylvia
    Welte, Tobias
    Corren, Jonathan
    JOURNAL OF ASTHMA AND ALLERGY, 2023, 16 : 915 - 932
  • [20] Tezepelumab efficacy in patients with severe, uncontrolled asthma and comorbid nasal polyps in NAVIGATOR
    Welte, T.
    Menzies-Gow, A.
    Israel, E.
    Corren, J.
    Hunter, G.
    Cook, W.
    Colice, G.
    Lanos-Ackert, P. J.
    PNEUMOLOGIE, 2022, 76 : S12 - S12
12345